Icon

BEVESPI AEROSPHERE (nda208294)- (0.0048MG/INH;0.0090MG/INH)

FORMOTEROL FUMARATE; GLYCOPYRROLATE ASTRAZENECA
0.0048MG/INH;0.0090MG/INH
No Yes
2031-Mar-17 Expired
None 2019-Apr-25
None No
BEVESPI AEROSPHERE is a combination of glycopyrrolate, an anticholinergic, and formoterol fumarate, a long-acting beta2-adrenergic agonist (LABA) indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
0 0 0
Total Other Developers 2
Drugs with Suitability No
0.0048MG/INH;0.0090MG/INH ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.